Nama Insights

Schrödinger (SDGR)

Healthcare · Health Information Services · NASDAQ

Schrödinger (SDGR) is a Healthcare company in the Health Information Services industry. It has a market capitalization of $2.23B and a free-cash-flow yield of 0.6%. Over the most recent reported fiscal year, revenue grew 23.3%. Nama's AI scorecard rates it Sell, 4.1 out of 10. On 12-month momentum it ranks in the rising band of its market.
AI scorecard
Sell · 4.1/10
Negative, at the mild end of Sell. As of Nov 7, 2026.
Momentum
Rising · +46.3% over 12 months ex. last
Second-best fifth of its market on the past year's move.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-49.7%
How far the last close sits under the highest price of the past five years.
Market cap$2.23B
Trailing P/E—
Price / book6.8
Price / sales8.6
FCF yield0.6%
Dividend yield—
Gross margin56.9%
Operating margin-59.2%
Net margin-21.0%
Revenue growth (YoY)+23.3%
Revenue growth (3-yr annual)+12.2%
EPS growth (YoY)—
FCF/share growth (YoY)—
Beta1.6
ExchangeNASDAQ
SectorHealthcare
IndustryHealth Information Services

SDGR earnings

Next report: Feb 24, 2027 (Q4 2026, EPS estimate -$0.20). Beat the EPS estimate in 2 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026 Nov 4, 2026 -$0.50 -$0.67 +25.4% $64.49M
Q2 2026 Aug 5, 2026 -$0.42 -$0.67 +37.3% $58.89M
Q1 2026 May 5, 2026 -$0.62 -$0.57 -8.8% $58.59M
Q4 2025 Feb 25, 2026 -$0.18 -$0.09 -100.0% $87.23M

SDGR analyst price target

Median target $30.00 from 7 analysts, ranging $17.00 – $32.00.

Health Information Services peers

TickerCompanyMarket capP/E
VEEV Veeva Systems $49.18B 35.0
TEM Tempus AI $13.87B —
BTSG BrightSpring Health Services $13.36B 39.3
HNGE Hinge Health $9.34B 51.7
HQY HealthEquity $8.57B 23.3
TXG 10x Genomics $7.72B 296.4
DOCS Doximity $5.79B 23.7
WAY Waystar $5.45B 17.2
Explore live SDGR data on Nama Insights →

SDGR FAQ

Is SDGR a buy?
Nama's AI scorecard currently rates Schrödinger Sell (4.1 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
When does SDGR report earnings?
Schrödinger's next scheduled report is on Feb 24, 2027. Analysts expect EPS of -$0.20.
What is the SDGR price target?
The median analyst price target from 7 analysts is $30.00, with a range of $17.00 – $32.00.
Is SDGR Shariah compliant?
Nama's AAOIFI-style screen reads Schrödinger as Can't Tell. A figure the screen needs is missing, so it can't tell.